Understanding Inborn Errors of Metabolism Through Metabolomics

Overview

Journal Metabolites

Publisher MDPI

Date 2022 May 28

PMID 35629902

Authors

Karen Driesen

Peter Witters

Affiliations

Soon will be listed here.

Abstract

Inborn errors of metabolism (IEMs) are rare diseases caused by a defect in a single enzyme, co-factor, or transport protein. For most IEMs, no effective treatment is available and the exact disease mechanism is unknown. The application of metabolomics and, more specifically, tracer metabolomics in IEM research can help to elucidate these disease mechanisms and hence direct novel therapeutic interventions. In this review, we will describe the different approaches to metabolomics in IEM research. We will discuss the strengths and weaknesses of the different sample types that can be used (biofluids, tissues or cells from model organisms; modified cell lines; and patient fibroblasts) and when each of them is appropriate to use.

Citing Articles

Analysis of human urinary extracellular vesicles reveals disordered renal metabolism in myotonic dystrophy type 1.

Kumari P, Sullivan L, Li Z, Parker Conquest E, Cornforth E, Jayakumar R Nat Commun. 2025; 16(1):2158.

PMID: 40044661 PMC: 11882899. DOI: 10.1038/s41467-025-56479-5.

Intra- and extracellular real-time analysis of perfused fibroblasts using an NMR bioreactor: A pilot study.

Urzi C, Meyer C, Mathis D, Vermathen P, Nuoffer J J Inherit Metab Dis. 2024; 48(1):e12794.

PMID: 39233469 PMC: 11667653. DOI: 10.1002/jimd.12794.

Single-cell metabolomics in rare disease: From technology to disease.

Li L, Zhang Y, Zhou J, Wang J, Wang L Intractable Rare Dis Res. 2024; 13(2):99-103.

PMID: 38836176 PMC: 11145402. DOI: 10.5582/irdr.2023.01073.

3D Printing of Dietary Products for the Management of Inborn Errors of Intermediary Metabolism in Pediatric Populations.

Carou-Senra P, Rodriguez-Pombo L, Monteagudo-Vilavedra E, Awad A, Alvarez-Lorenzo C, Basit A Nutrients. 2024; 16(1).

PMID: 38201891 PMC: 10780524. DOI: 10.3390/nu16010061.

Metabolomic Studies in Inborn Errors of Metabolism: Last Years and Future Perspectives.

Cossu M, Pintus R, Zaffanello M, Mussap M, Serra F, Marcialis M Metabolites. 2023; 13(3).

PMID: 36984887 PMC: 10058105. DOI: 10.3390/metabo13030447.

References

Marin-Valencia I, Good L, Ma Q, Duarte J, Bottiglieri T, Sinton C . Glut1 deficiency (G1D): epilepsy and metabolic dysfunction in a mouse model of the most common human phenotype. Neurobiol Dis. 2012; 48(1):92-101. PMC: 3495165. DOI: 10.1016/j.nbd.2012.04.011. View

Liang L, Sun F, Wang H, Hu Z . Metabolomics, metabolic flux analysis and cancer pharmacology. Pharmacol Ther. 2021; 224:107827. DOI: 10.1016/j.pharmthera.2021.107827. View

Johnson C, Ivanisevic J, Siuzdak G . Metabolomics: beyond biomarkers and towards mechanisms. Nat Rev Mol Cell Biol. 2016; 17(7):451-9. PMC: 5729912. DOI: 10.1038/nrm.2016.25. View

Cappuccio G, Pinelli M, Alagia M, Donti T, Day-Salvatore D, Veggiotti P . Biochemical phenotyping unravels novel metabolic abnormalities and potential biomarkers associated with treatment of GLUT1 deficiency with ketogenic diet. PLoS One. 2017; 12(9):e0184022. PMC: 5621665. DOI: 10.1371/journal.pone.0184022. View

Tebani A, Schmitz-Afonso I, Abily-Donval L, Heron B, Piraud M, Ausseil J . Urinary metabolic phenotyping of mucopolysaccharidosis type I combining untargeted and targeted strategies with data modeling. Clin Chim Acta. 2017; 475:7-14. DOI: 10.1016/j.cca.2017.09.024. View

Ferreira C, van Karnebeek C . Inborn errors of metabolism. Handb Clin Neurol. 2019; 162():449-481. PMC: 11755387. DOI: 10.1016/B978-0-444-64029-1.00022-9. View

Hannibal L, Theimer J, Wingert V, Klotz K, Bierschenk I, Nitschke R . Metabolic Profiling in Human Fibroblasts Enables Subtype Clustering in Glycogen Storage Disease. Front Endocrinol (Lausanne). 2020; 11:579981. PMC: 7719825. DOI: 10.3389/fendo.2020.579981. View

Ferreira C, Rahman S, Keller M, Zschocke J . An international classification of inherited metabolic disorders (ICIMD). J Inherit Metab Dis. 2020; 44(1):164-177. PMC: 9021760. DOI: 10.1002/jimd.12348. View

van Karnebeek C, Stockler S . Treatable inborn errors of metabolism causing intellectual disability: a systematic literature review. Mol Genet Metab. 2012; 105(3):368-81. DOI: 10.1016/j.ymgme.2011.11.191. View

10.

Morava E, Schatz U, Torring P, Abbott M, Baumann M, Brasch-Andersen C . Impaired glucose-1,6-biphosphate production due to bi-allelic PGM2L1 mutations is associated with a neurodevelopmental disorder. Am J Hum Genet. 2021; 108(6):1151-1160. PMC: 8206387. DOI: 10.1016/j.ajhg.2021.04.017. View

11.

Ichikawa M, Scott D, Losfeld M, Freeze H . The metabolic origins of mannose in glycoproteins. J Biol Chem. 2014; 289(10):6751-6761. PMC: 3945336. DOI: 10.1074/jbc.M113.544064. View

12.

Falk M, Zhang Z, Rosenjack J, Daikhin E, Nissim I, Sedensky M . Metabolic pathway profiling of mitochondrial respiratory chain mutants in C. elegans. Mol Genet Metab. 2008; 93(4):388-97. PMC: 2424222. DOI: 10.1016/j.ymgme.2007.11.007. View

13.

El-Hattab A, Hsu J, Emrick L, Wong L, Craigen W, Jahoor F . Restoration of impaired nitric oxide production in MELAS syndrome with citrulline and arginine supplementation. Mol Genet Metab. 2012; 105(4):607-14. PMC: 4093801. DOI: 10.1016/j.ymgme.2012.01.016. View

14.

Lu L, Xia Z, Guo J, Xiao L, Zhang Y . Metabolomics analysis reveals perturbations of cerebrocortical metabolic pathways in the Pah mouse model of phenylketonuria. CNS Neurosci Ther. 2019; 26(4):486-493. PMC: 7080435. DOI: 10.1111/cns.13214. View

15.

Sklirou E, Alodaib A, Dobrowolski S, Mohsen A, Vockley J . Physiological Perspectives on the Use of Triheptanoin as Anaplerotic Therapy for Long Chain Fatty Acid Oxidation Disorders. Front Genet. 2021; 11:598760. PMC: 7875087. DOI: 10.3389/fgene.2020.598760. View

16.

Nota B, Struys E, Pop A, Jansen E, Ojeda M, Kanhai W . Deficiency in SLC25A1, encoding the mitochondrial citrate carrier, causes combined D-2- and L-2-hydroxyglutaric aciduria. Am J Hum Genet. 2013; 92(4):627-31. PMC: 3617390. DOI: 10.1016/j.ajhg.2013.03.009. View

17.

Guthrie R, Susi A . A SIMPLE PHENYLALANINE METHOD FOR DETECTING PHENYLKETONURIA IN LARGE POPULATIONS OF NEWBORN INFANTS. Pediatrics. 1963; 32:338-43. View

18.

de Groot M, Hoeksma M, Blau N, Reijngoud D, van Spronsen F . Pathogenesis of cognitive dysfunction in phenylketonuria: review of hypotheses. Mol Genet Metab. 2010; 99 Suppl 1:S86-9. DOI: 10.1016/j.ymgme.2009.10.016. View

19.

Ney D, Murali S, Stroup B, Nair N, Sawin E, Rohr F . Metabolomic changes demonstrate reduced bioavailability of tyrosine and altered metabolism of tryptophan via the kynurenine pathway with ingestion of medical foods in phenylketonuria. Mol Genet Metab. 2017; 121(2):96-103. PMC: 5484416. DOI: 10.1016/j.ymgme.2017.04.003. View

20.

Robert Bao X, Ong S, Goldberger O, Peng J, Sharma R, Thompson D . Mitochondrial dysfunction remodels one-carbon metabolism in human cells. Elife. 2016; 5. PMC: 4911214. DOI: 10.7554/eLife.10575. View